, Columnists
Monsanto Accepts Reality
Even without a knockout bid from Bayer, the deal makes sense for the seed giant and its shareholders.
This article is for subscribers only.
It's on.
After months of back-and-forth between Bayer and Monsanto, the two sides have agreed to the year's biggest takeover. The German life sciences group secured the backing of the U.S. seeds giant for a sweetened offer of $128 a share, valuing the target at $66 billion including debt. The new terms include an increased break fee of $2 billion should antitrust regulators block the transaction.